Somatic Mutation

15 registered clinical trials studyying Somatic Mutation — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations NCT06895681	University of California, San Francisco	—
Enrolling By Invitation	Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in G NCT06917794	D'Or Institute for Research and Education	—
Enrolling By Invitation	SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues NCT06832150	The Wellcome Sanger Institute	—
Recruiting	Linking Somatic Mutation Rate With Baseline Exposure in East Palestine NCT06357845	Case Comprehensive Cancer Center	N/A
Enrolling By Invitation	Somatic Mutation in Chronic Liver Disease NCT06656767	The Wellcome Sanger Institute	—
Recruiting	Somatic Mosaicism in Twins Discordant for Childhood Cancer NCT06054295	Children's Oncology Group	—
Not Yet Recruiting	Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study NCT04788927	Rigshospitalet, Denmark	—
Recruiting	MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717	Masonic Cancer Center, University of Minnesota	Phase 2
Recruiting	Molecular Diagnosis of Systemic Autoinflammatory Diseases NCT05364294	Institut National de la Santé Et de la Recherche Médicale, France	—
Unknown	Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation NCT04516083	RWJ Barnabas Health at Jersey City Medical Center	—
Completed	iSITE: Investigation of Somatic Alterations in Tumours of the Eye NCT06861647	The Wellcome Sanger Institute	—
Enrolling By Invitation	Exploring the Landscape of Somatic Mutations in Human Tissue NCT06585800	The Wellcome Sanger Institute	—
Enrolling By Invitation	SMS - Study of Somatic Mutations Using Genome Sequencing NCT06851052	The Wellcome Sanger Institute	—
Unknown	A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor T NCT03092128	Xueding Wang	—
Recruiting	A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment NCT01994057	Sun Yat-sen University	—